{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T23:33:13Z","timestamp":1790811193765,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"vor","delay-in-days":366,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jidonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Investigative Dermatology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1038\/jid.2015.376","type":"journal-article","created":{"date-parts":[[2015,9,29]],"date-time":"2015-09-29T11:50:47Z","timestamp":1443527447000},"page":"481-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["BRAF and RAS Mutations in Sporadic and Secondary Pyogenic Granuloma"],"prefix":"10.1016","volume":"136","author":[{"given":"Leopold","family":"Groesser","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Peterhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Evert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Landthaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Berneburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hafner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/JID.2015.376_bib1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1073\/pnas.94.3.861","article-title":"Oncogenic H-ras stimulates tumor angiogenesis by two distinct pathways","volume":"94","author":"Arbiser","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/JID.2015.376_bib2","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/ng.2921","article-title":"Recurrent PTPRB and PLCG1 mutations in angiosarcoma","volume":"46","author":"Behjati","year":"2014","journal-title":"Nat Genet"},{"key":"10.1038\/JID.2015.376_bib3","doi-asserted-by":"crossref","first-page":"E353","DOI":"10.1073\/pnas.1105026109","article-title":"Targeting oncogenic serine\/threonine-protein kinase BRAF in cancer cells inhibits angiogenesis and abrogates hypoxia","volume":"109","author":"Bottos","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/JID.2015.376_bib4","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/nature00766","article-title":"Mutations of the BRAF gene in human cancer","volume":"417","author":"Davies","year":"2002","journal-title":"Nature"},{"key":"10.1038\/JID.2015.376_bib5","doi-asserted-by":"crossref","first-page":"e87966","DOI":"10.1371\/journal.pone.0087966","article-title":"GNAS mutations identify a set of right-sided, RAS mutant, villous colon cancers","volume":"9","author":"Fecteau","year":"2014","journal-title":"PloS One"},{"key":"10.1038\/JID.2015.376_bib6","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0190-9622(00)90138-5","article-title":"Vascular tumors and vascular malformations: evidence for an association","volume":"42","author":"Garzon","year":"2000","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1038\/JID.2015.376_bib7","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jaad.2006.05.069","article-title":"Vascular malformations: part I","volume":"56","author":"Garzon","year":"2007","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1038\/JID.2015.376_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/DAD.0b013e31828c0542","article-title":"Low incidence of oncogenic EGFR, HRAS, and KRAS mutations in seborrheic keratosis","volume":"36","author":"Georgieva","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"10.1038\/JID.2015.376_bib9","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1038\/jid.2014.360","article-title":"RAS mutations in benign epithelial tumors associated with BRAF inhibitor treatment of melanoma","volume":"135","author":"Hassel","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.376_bib10","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/bjd.12448","article-title":"An update on infantile haemangiomas","volume":"169","author":"Hoeger","year":"2013","journal-title":"Br J Dermatol"},{"key":"10.1038\/JID.2015.376_bib11","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/jid.2015.55","article-title":"Somatic activating RAS mutations cause vascular tumors including pyogenic granuloma","volume":"135","author":"Lim","year":"2015","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.376_bib12","doi-asserted-by":"crossref","first-page":"e8802","DOI":"10.1371\/journal.pone.0008802","article-title":"Two multiplex assays that simultaneously identify 22 possible mutation sites in the KRAS, BRAF, NRAS and PIK3CA genes","volume":"5","author":"Lurkin","year":"2010","journal-title":"PloS One"},{"key":"10.1038\/JID.2015.376_bib13","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1038\/sj.onc.1206921","article-title":"Activated Ras induces a proangiogenic phenotype in primary endothelial cells","volume":"23","author":"Meadows","year":"2004","journal-title":"Oncogene"},{"key":"10.1038\/JID.2015.376_bib14","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1093\/carcin\/bgp337","article-title":"Targets of Raf in tumorigenesis","volume":"31","author":"Niault","year":"2010","journal-title":"Carcinogenesis"},{"key":"10.1038\/JID.2015.376_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.0736-8046.2004.21102.x","article-title":"Pyogenic granuloma in children","volume":"21","author":"Pagliai","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1038\/JID.2015.376_bib16","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1111\/j.1525-1470.1991.tb00931.x","article-title":"Pyogenic granuloma (lobular capillary hemangioma): a clinicopathologic study of 178 cases","volume":"8","author":"Patrice","year":"1991","journal-title":"Pediatr Dermatol"},{"key":"10.1038\/JID.2015.376_bib17","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1038\/sj.jid.5700723","article-title":"BRAF mutations in multiple sebaceous hyperplasias of patients belonging to MYH-associated polyposis pedigrees","volume":"127","author":"Ponti","year":"2007","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1038\/JID.2015.376_bib18","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1056\/NEJMc1407683","article-title":"Pyogenic granuloma as a cutaneous adverse effect of vemurafenib","volume":"371","author":"Sammut","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1038\/JID.2015.376_bib19","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.humpath.2014.11.002","article-title":"Activating mutations in the RAS\/mitogen-activated protein kinase signaling pathway in sporadic trichoblastoma and syringocystadenoma papilliferum","volume":"46","author":"Shen","year":"2015","journal-title":"Human pathology"},{"key":"10.1038\/JID.2015.376_bib20","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/archophthalmol.2011.135","article-title":"Phacomatosis pigmentovascularis of cesioflammea type in 7 patients: combination of ocular pigmentation (melanocytosis or melanosis) and nevus flammeus with risk for melanoma","volume":"129","author":"Shields","year":"2011","journal-title":"Arch Ophthalmol"},{"key":"10.1038\/JID.2015.376_bib21","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1056\/NEJMoa1213507","article-title":"Sturge-Weber syndrome and port-wine stains caused by somatic mutation in GNAQ","volume":"368","author":"Shirley","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1038\/JID.2015.376_bib22","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1056\/NEJMoa1105358","article-title":"RAS mutations in cutaneous squamous-cell carcinomas in patients treated with BRAF inhibitors","volume":"366","author":"Su","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1038\/JID.2015.376_bib23","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1056\/NEJMoa1000584","article-title":"Mutations in GNA11 in uveal melanoma","volume":"363","author":"Van Raamsdonk","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1038\/JID.2015.376_bib24","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nrm1498","article-title":"The RAF proteins take centre stage","volume":"5","author":"Wellbrock","year":"2004","journal-title":"Nat Rev Mol Cell Biol"}],"container-title":["Journal of Investigative Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15000263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022202X15000263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,23]],"date-time":"2018-11-23T09:39:28Z","timestamp":1542965968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022202X15000263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":24,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0022202X15000263"],"URL":"https:\/\/doi.org\/10.1038\/jid.2015.376","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725818438.793558672","asserted-by":"object"}]},"ISSN":["0022-202X"],"issn-type":[{"value":"0022-202X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BRAF and RAS Mutations in Sporadic and Secondary Pyogenic Granuloma","name":"articletitle","label":"Article Title"},{"value":"Journal of Investigative Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/JID.2015.376","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}